Oxford University-spinout OxSyBio has raised £10m ($14m) to develop a 3D human organ printing platform. The biotech start-up's system uses living cells to generate non-living "artificial" cells and create therapeutic tissues that can repair or replace damaged body parts. It's hoped the system will ease a shortage of donor organs. Woodford Investment Management said the funding would help the start-up to create "disruptive products that harness the power of biology for impact in medicine". Funding was led by Oxford University Innovation.
Oxford University-spinout OxSyBio has raised £10m ($14m) to develop a 3D human organ printing platform. The biotech start-up's system uses living cells to generate non-living "artificial" cells and create therapeutic tissues that can repair or replace damaged body parts. It's hoped the system will ease a shortage of donor organs. Oxford University Innovation said the funding would help the start-up to create "disruptive products that harness the power of biology for impact in medicine". Funding was led by Woodford Investment Management.